KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to $10.2 million.

  • Rigel Pharmaceuticals' Prepaid Assets rose 85.67% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 85.67%. This contributed to the annual value of $10.2 million for FY2024, which is 62.35% up from last year.
  • According to the latest figures from FY2024, Rigel Pharmaceuticals' Prepaid Assets is $10.2 million, which was up 62.35% from $6.3 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Prepaid Assets registered a high of $14.0 million during FY2020, and its lowest value of $6.3 million during FY2023.
  • Moreover, its 3-year median value for Prepaid Assets was $8.3 million (2022), whereas its average is $8.2 million.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Prepaid Assets plummeted by 47.23% in 2021, and later spiked by 62.35% in 2024.
  • Rigel Pharmaceuticals' Prepaid Assets (Yearly) stood at $14.0 million in 2020, then slumped by 47.23% to $7.4 million in 2021, then climbed by 11.43% to $8.3 million in 2022, then dropped by 24.19% to $6.3 million in 2023, then skyrocketed by 62.35% to $10.2 million in 2024.